Background: The aim of this study was to investigate the applicability of the central line-associated bloodstream infection (CLABSI) criteria of the Centers for Disease Control and Prevention in pediatric oncology patients.
Methods: Bacteremia episodes from 2020 to 2022 from a prospective cohort of pediatric oncology patients with a central venous catheter were included. Episodes were classified by three medical experts following the CLABSI criteria as either a CLABSI or non-CLABSI (i.e., contamination, other infection source, or mucosal barrier injury-laboratory confirmed bloodstream infection (MBI-LCBI)). Subsequently, they were asked if and why they (dis)agreed with this diagnosis following the criteria. The primary outcome was the percentage of episodes where the experts clinically disagreed with the diagnosis given following the CLABSI criteria.
Results: Overall, 84 bacteremia episodes in 71 patients were evaluated. Following the CLABSI criteria, 34 (40%) episodes were classified as CLABSIs and 50 (60%) as non-CLABSIs. In 11 (13%) cases the experts clinically disagreed with the diagnosis following the CLABSI criteria. The discrepancy between the CLABSI criteria and clinical diagnosis was significant; McNemar's test p < .01. Disagreement by the experts with the CLABSI criteria mostly occurred when the experts found an MBI-LCBI a more plausible cause of the bacteremia than a CLABSI due to the presence of a gram negative bacteremia (Pseudomonas aeruginosa n = 3) and/or mucositis.
Conclusions: A discrepancy between the CLABSI criteria and the evaluation of the experts was observed. Adding Pseudomonas aeruginosa as an MBI pathogen and incorporating the presence of mucositis in the MBI-LCBI criteria, might increase the applicability.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/ejh.14175 | DOI Listing |
J Eval Clin Pract
November 2024
Department of Respiratory Traditional Chinese Medicine Ward, Afffliated Hospital of Hebei Engineering University, Handan, Hebei, China.
Int J Infect Dis
January 2025
Department of Infection Prevention, International Society of Infectious Diseases; Mayo Clinic Health Care System, Eau Claire, WI, USA.
A panel of experts convened by the International Society for Infectious Diseases (ISID) has reviewed and consolidated current recommendations for preventing vascular catheter infections, particularly central line-associated bloodstream infections (CLABSIs). This review provides healthcare professionals with insights into key issues such as the rates of CLABSI in high-income countries and low- and middle-income countries, the attributable extra length of stay, cost and mortality, and risk factors. This position paper highlights evidence-based strategies for preventing infections, applicable to both high-income and low- and middle-income countries.
View Article and Find Full Text PDFJ Infect Prev
September 2024
Department of Pharmacy Services, Cooper University Healthcare, Camden, NJ, USA.
Background: In 2020, as a result of evidence of demonstrated safety of an initial pilot program, our institution set out to implement a peripheral vasopressor infusion protocol.
Objective: To evaluate the use of peripheral lines for vasopressor administration to reduce placement of unnecessary central lines and central line days.
Methods: This is an Institutional Review Board approved, single center retrospective chart review conducted as pre/post-analysis.
Cureus
September 2024
Biostatistics, High Institute of Public Health, Alexandria University, Alexandria, EGY.
Infect Control Hosp Epidemiol
October 2024
Division of Infectious Diseases, Department of Medicine, School of Medicine, Emory University, Atlanta, GA, USA.
Objective: To examine the relationship between race and ethnicity and central line-associated bloodstream infections (CLABSI) while accounting for inherent differences in CLABSI risk related to central venous catheter (CVC) type.
Design: Retrospective cohort analysis.
Setting: Acute care facilities within an academic healthcare system.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!